Pathogenetic therapy of cognitive impairment: results of a multicenter placebo-controlled clinical trial of the efficacy and safety of Miladean-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pathogenetic therapy of cognitive impairment: results of a multicenter placebo-controlled clinical trial of the efficacy and safety of Miladean

Published:2023 Issue:10 Volume:123 Page:60
ISSN:1997-7298
Container-title:Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
language:en
Short-container-title:Z. nevrol. psikhiatr. im. S.S. Korsakova

Author:

Levin O.S.^ORCID,Zakharov V.V.^ORCID,Khacheva K.K.^ORCID,Vladykin A.L.^ORCID,Globenko A.A.^ORCID

Publisher

Media Sphere Publishing Group

Subject

Psychiatry and Mental health,Neurology (clinical)

Reference32 articles.

1. Morley JE. An overview of cognitive impairment. Clin Geriat Med. 2018;34(4):505-513

2. Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging. 2009;30(4):507-514

3. Deary I. Age-associated cognitive decline. Br Med Bul. 2009;92(1):135-152

4. Zakharov VV. Prevalence and treatment of cognitive disorders in a neurological clinic. The results of the All-Russian PROMETHEUS study. Consilium Medicum. 2008;10(2):114-117. (In Russ.)

5. Geda YE, Roberts RO, Knopman DS. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry. 2008;65(10):1193-1198

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP